UniSa - IRIS Institutional Research Information System

BARONE, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 31.688
NA - Nord America 19.739
EU - Europa 6.729
SA - Sud America 1.924
OC - Oceania 209
AF - Africa 142
Continente sconosciuto - Info sul continente non disponibili 19
Totale 60.450
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 23.101
US - Stati Uniti d'America 19.383
SG - Singapore 4.075
CN - Cina 2.164
BR - Brasile 1.586
IT - Italia 1.476
UA - Ucraina 1.422
VN - Vietnam 963
RU - Federazione Russa 923
DE - Germania 784
IE - Irlanda 633
KR - Corea 450
TR - Turchia 405
SE - Svezia 353
FI - Finlandia 314
GB - Regno Unito 250
CA - Canada 208
EE - Estonia 146
IN - India 136
AR - Argentina 132
NZ - Nuova Zelanda 104
AU - Australia 99
MX - Messico 87
PL - Polonia 72
BD - Bangladesh 64
EC - Ecuador 62
NL - Olanda 62
AT - Austria 56
JP - Giappone 55
FR - Francia 51
ES - Italia 47
ID - Indonesia 45
IQ - Iraq 41
ZA - Sudafrica 37
CO - Colombia 33
CZ - Repubblica Ceca 30
PK - Pakistan 28
MA - Marocco 25
PY - Paraguay 25
UZ - Uzbekistan 25
VE - Venezuela 25
CL - Cile 23
IL - Israele 20
EU - Europa 16
AE - Emirati Arabi Uniti 15
LT - Lituania 15
DO - Repubblica Dominicana 14
PE - Perù 14
EG - Egitto 13
UY - Uruguay 13
BE - Belgio 11
KE - Kenya 11
AZ - Azerbaigian 10
BG - Bulgaria 9
BO - Bolivia 9
AL - Albania 8
ET - Etiopia 8
IR - Iran 8
JM - Giamaica 8
NP - Nepal 8
SA - Arabia Saudita 8
DK - Danimarca 7
DZ - Algeria 7
TN - Tunisia 7
CH - Svizzera 6
CR - Costa Rica 6
JO - Giordania 6
BA - Bosnia-Erzegovina 5
BW - Botswana 5
GR - Grecia 5
OM - Oman 5
PH - Filippine 5
RO - Romania 5
SV - El Salvador 5
TW - Taiwan 5
BY - Bielorussia 4
CI - Costa d'Avorio 4
HN - Honduras 4
KZ - Kazakistan 4
LB - Libano 4
LU - Lussemburgo 4
ME - Montenegro 4
PA - Panama 4
PR - Porto Rico 4
PT - Portogallo 4
RS - Serbia 4
BH - Bahrain 3
GE - Georgia 3
HU - Ungheria 3
KG - Kirghizistan 3
LV - Lettonia 3
MN - Mongolia 3
MY - Malesia 3
NG - Nigeria 3
NI - Nicaragua 3
NO - Norvegia 3
QA - Qatar 3
SK - Slovacchia (Repubblica Slovacca) 3
SO - Somalia 3
SY - Repubblica araba siriana 3
Totale 60.383
Salva come PNG Salva come JPEG
Città #
Hong Kong 23.082
Ann Arbor 4.156
Wilmington 2.250
Singapore 1.899
Jacksonville 1.729
Princeton 1.634
Chandler 1.535
Dallas 1.122
Ashburn 753
Houston 742
Woodbridge 616
Dublin 594
Dong Ket 459
Beijing 401
Nanjing 399
Andover 368
Izmir 364
Moscow 314
Boardman 298
Pellezzano 264
Düsseldorf 216
Mestre 203
Ho Chi Minh City 190
Los Angeles 186
Naples 149
Tallinn 146
Norwalk 143
São Paulo 141
Shenyang 134
Fairfield 131
The Dalles 123
Salerno 122
Hebei 121
Munich 121
New York 119
Changsha 113
Nanchang 108
Dearborn 107
Hanoi 93
Jiaxing 85
Rome 71
Redwood City 60
Warsaw 59
Nuremberg 57
Tianjin 56
Rio de Janeiro 55
Brooklyn 52
Montreal 50
San Diego 49
Pune 48
Santa Clara 46
Tokyo 44
Auckland 43
Stockholm 43
Columbus 42
Sydney 42
Milan 40
San Francisco 38
Council Bluffs 37
Seoul 37
Belo Horizonte 36
Amsterdam 35
Seattle 35
Turku 35
West Jordan 35
Boston 34
Orem 34
Curitiba 33
Washington 33
Atlanta 31
Brasília 31
Cambridge 31
Phoenix 30
Poplar 30
Denver 29
Jinan 29
Casoria 28
Chicago 27
London 27
Ottawa 27
Haiphong 25
Johannesburg 25
Chennai 24
Guangzhou 24
Porto Alegre 24
Guayaquil 23
Lappeenranta 23
Tashkent 22
Campinas 21
Fort Worth 21
Toronto 21
Ankara 20
Guarulhos 19
Quito 19
Springfield 19
Vienna 19
Baghdad 18
Shanghai 18
Venezia 18
Melbourne 17
Totale 47.749
Salva come PNG Salva come JPEG
Nome #
Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables 1.172
Step length predicts executive dysfunction in Parkinson’s disease: a 3-year prospective study 966
Longitudinal change of energy expenditure, body composition and dietary habits in Progressive Supranuclear Palsy patients 932
Managing Device-Aided Treatments in Parkinson's Disease in Times of COVID-19 918
Trial of Deferiprone in Parkinson's Disease 658
Sex Differences in Parkinson’s Disease: From Bench to Bedside 631
Quantitative gait assessment in Parkinsonian patients with or without Mild Cognitive Impairment 586
Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study 578
Cognitive impairment in nondemented Parkinson's disease. 565
Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations 561
Success rate, efficacy, and safety/tolerability of overnight switching from immediate- to extended-release pramipexole in advanced Parkinson's disease. 531
Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease. 531
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 523
Gender differences in microRNA expression in levodopa-naive PD patients 521
A simulation tool to plan daily nurse requirements 509
Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclearpalsy. 505
Gait Analysis in Progressive Supranuclear Palsy Phenotypes. 497
Combined regional T1w/T2w ratio and voxel-based morphometry in multiple system atrophy: A follow-up study 483
Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease. Apr 30;24(6):899-905.PMID: 19205072 459
Psychometric properties of the Beck Depression Inventory-II in progressive supranuclear palsy 443
Quality of Life and Nonmotor Symptoms in Parkinson's Disease 440
Motor and Sensory Features of Cervical Dystonia Subtypes: Data From the Italian Dystonia Registry 433
White matter changes and the development of motor phenotypes in de novo Parkinson's Disease 431
Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease. 416
Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease. 413
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 412
Rare causes of early-onset dystonia-parkinsonism with cognitive impairment: a de novo PSEN-1 mutation 395
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life. 377
Fist-Palm Test May Identify Mild Cognitive Impairment and Freezing of Gait in Parkinson's Disease: A Machine Learning Approach 376
Fist-Palm Test (FiPaT): a bedside motor tool to screen for global cognitive status 368
Neurotransmission in Parkinson's disease: beyond dopamine. 356
Energy expenditure, body composition and dietary habits in progressive supranuclear palsy 340
Effects of Safinamide on Pain in Fluctuating Parkinson's Disease Patients: A Post-Hoc Analysis 337
Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review 313
Bilateral facial palsy after COVID-19 vaccination 311
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 309
Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson'sdisease in Italians 305
Clinical and Molecular Characterization of a Novel Progranulin Deletion Associated with Different Phenotypes 301
Apathy evaluation scale-informant version in progressive supranuclear palsy: Psychometric properties and clinical correlates 298
Extended-release pramipexole in advanced Parkinson disease: a randomized controlled trial 295
A longitudinal study of cognitive dysfunction in patients affected by Parkinson’s disease with and without freezing of gait 293
Magnetic resonance T1w/T2w ratio and voxel-based morphometry in multiple system atrophy 293
A novel phenotype in an Italian family with a rare progranulin mutation 279
Association study between the LINGO1 gene and Parkinson's disease in the Italian population 277
Effect of Global Postural Rehabilitation program on spatiotemporal gait parameters of parkinsonian patients: a three-dimensional motion analysis study. 268
Relationship Between Orthostatic Hypotension and Cognitive Functions in Multiple System Atrophy: A Longitudinal Study 267
Dual-task-related gait patterns as possible marker of precocious and subclinical cognitive alterations in Parkinson disease 261
Trial of Cinpanemab in Early Parkinson's Disease 251
Validation of the Italian version of Parkinson's Disease-Cognitive Rating Scale (PD-CRS) 250
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 248
Classifying Different Stages of Parkinson’s Disease Through Random Forests 243
Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease 237
Hypomorphic NOTCH3 mutation in an Italian family with CADASIL features 232
Metabolomics in Parkinson's disease 231
A Bayesian approach to Essential Tremor plus: A preliminary analysis of the TITAN cohort 216
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 204
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 202
Apoptotic mechanisms in mutant LRRK2-mediated cell death. 196
Personality in Parkinson's disease: Clinical, behavioural and cognitive correlates 196
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 192
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 189
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 180
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkindisease 175
Linguistic, psychometric validation and diagnostic ability assessment of an Italian version of a 19-item wearing-off questionnaire for wearing-off detection in Parkinson's disease. 171
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. 170
Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson's disease. 170
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 168
MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. 167
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 162
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 159
Adherence to anti-Parkinson drug therapy in the ?REASON? sample of Italian patients with Parkinson?s disease: the linguistic validation of the Italian version of the ?Morisky Medical Adherence scale-8 items? 153
Measurements of Postural Sway to Classify Freezing of Gait in Parkinson's Disease 152
Accuracy of clinical diagnostic criteria for Friedreich'sataxia. 150
Cerebellar ataxia associated with subclinical celiac disease responding togluten-free diet 149
Machine learning can detect the presence of Mild cognitive impairment in patients affected by Parkinson’s Disease 148
Application of the mPSPRS to the Salerno Cohort and a Comparison Between PSP-RS and vPSP 148
Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study 145
Progression of multiple system atrophy (MSA): a prospective natural history studyby the European MSA Study Group (EMSA SG) 143
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 141
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 141
Neuropsychological correlates of Pisa syndrome in patients with Parkinson's disease 141
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 140
Affective theory of mind in patients with Parkinson's disease: comment 137
A window into the mind-brain-body interplay: Development of diagnostic, prognostic biomarkers, and rehabilitation strategies in functional motor disorders 135
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 135
Serum miR-30c-5p is a potential biomarker for multiple system atrophy 133
Increased bilirubin levels in de novo Parkinson's disease 131
The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study. 130
The natural history of multiple system atrophy: A prospective European cohort study 128
APP-Related Corticobasal Syndrome: Expanding the List of Corticobasal Degeneration Look Alikes 128
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 128
Are granular osmiophilic material deposits an epiphenomenon in CADASIL? 127
An easy tool to improve accuracy in pre-diagnostic Parkinson's disease population 127
Normative data for the Montreal Cognitive Assessment in an Italian population sample 125
A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson's disease patients 124
Quitting smoking: An early non-motor feature of Parkinson's disease? 123
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 123
Spread of dystonia in patients with idiopathic adult-onset laryngeal dystonia 123
Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. 122
The PRIAMO study: background, methods and recruitment. Apr;29(2):61-5. .PMID: 18483702 121
Totale 30.393
Salva come PNG Salva come JPEG
Categoria #
all - tutte 190.606
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 190.606
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.730 0 0 0 0 0 136 344 19 305 22 341 563
2021/20222.615 14 4 14 25 23 16 40 112 405 368 356 1.238
2022/20234.002 472 174 97 355 656 927 20 382 628 18 187 86
2023/20242.059 159 310 110 162 100 197 86 131 71 138 175 420
2024/20256.305 260 60 145 369 216 669 731 686 911 692 741 825
2025/202630.493 4.870 11.165 9.973 1.342 2.392 751 0 0 0 0 0 0
Totale 61.528